Soleno Therapeutics Inc’s filing revealed that its insider Hirano Patricia C unloaded Company’s shares for reported $0.27 million on Apr 01 ’25. In the deal valued at $70.11 per share,3,782 shares were sold. As a result of this transaction, Hirano Patricia C now holds 27,036 shares worth roughly $2.1 million.
Then, PATRICIA HIRANO bought 3,782 shares, generating $265,156 in total proceeds.
Before that, Pauls Matthew sold 5,937 shares. Soleno Therapeutics Inc shares valued at $424,797 were divested by the Director at a price of $71.55 per share. As a result of the transaction, Pauls Matthew now holds 6,500 shares, worth roughly $0.51 million.
A number of analysts have revised their coverage, including Stifel’s analysts, who remained covering the stock and in early December has reiterated a ‘”a Buy”‘ rating for it. Robert W. Baird also remained covering SLNO and reiterated its “an Outperform” recommendation on December 02, 2024. H.C. Wainwright started covering the stock on September 03, 2024. It rated SLNO as “a Buy”.
Price Performance Review of SLNO
On Monday, Soleno Therapeutics Inc [NASDAQ:SLNO] saw its stock jump 2.94% to $77.73. Over the last five days, the stock has gained 2.74%. Soleno Therapeutics Inc shares have risen nearly 72.93% since the year began. Nevertheless, the stocks have risen 74.48% over the past one year. While a 52-week high of $80.99 was reached on 05/08/25, a 52-week low of $36.93 was recorded on 01/15/25. SMA at 50 days reached $72.96, while 200 days put it at $55.63.
Levels Of Support And Resistance For SLNO Stock
The 24-hour chart illustrates a support level at 76.41, which if violated will result in even more drops to 75.10. On the upside, there is a resistance level at 78.63. A further resistance level may holdings at 79.54. The Relative Strength Index (RSI) on the 14-day chart is 59.32, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.53, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 15.62%. Stochastics %K at 60.91% indicates the stock is a holding.
The most recent change occurred on May 10, 2024 when Robert W. Baird began covering the stock and recommended ‘”an Outperform”‘ rating along with a $72 price target.
